Press Releases

Welcome to the Investing News Network's press release section, where you can stay informed with past and present announcements from our clients. Explore the latest stock news from mining, technology and life science companies and gain an investing edge by staying up to date with today's press releases.
Filters
Clear All Filters
Filter ✕

Date Range

Sector

InMed Pharmaceuticals (INM)

InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance

pharmaceutical investing
InMed Pharmaceuticals (INM)

InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program

pharmaceutical investing
Solvonis Therapeutics (None)

SVN-114 selected as the lead candidate for PTSD discovery programme

pharmaceutical investing
InMed Pharmaceuticals (INM)

InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial

pharmaceutical investing
InMed Pharmaceuticals (INM)

InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline

pharmaceutical investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference

biotech investing
InMed Pharmaceuticals (INM)

InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update

pharmaceutical investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure

biotech investing
Seegnal (SEGN:CA)

Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

biotech investing
Lobe Sciences (LOBE:CC)

Lobe Sciences Reports First Quarter 2026 Results and Highlights

psychedelics investing
Seegnal (SEGN:CA)

Seegnal Presents Real-World Evidence on Reducing Fall Risk in Geriatric Patients at Caltcm Summit

medical device investing
Solvonis Therapeutics (None)

Expansion of SVN-015 into Depression Following Positive Preclinical Data

pharmaceutical investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

biotech investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

biotech investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

biotech investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

biotech investing
Lobe Sciences (LOBE:CC)

Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors

psychedelics investing
Lobe Sciences (LOBE:CC)

Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy

psychedelics investing
Solvonis Therapeutics (None)

U.S. Patent allowance received for PTSD discovery programme

psychedelics investing
Lobe Sciences (LOBE:CC)

Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition

psychedelics investing

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES